Skip to content

Evaluation of a Patient Decision Aid for Emergency Department Initiated Buprenorphine

CTN-0156: Pilot Development and Evaluation of a Patient Decision Aid for Emergency Department Initiated Buprenorphine

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07278518
Enrollment
20
Registered
2025-12-12
Start date
2026-08-13
Completion date
2027-02-13
Last updated
2026-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid Use Disorder

Keywords

buprenorphine, patient decision aid, emergency department

Brief summary

This study aims to develop and pilot test a patient decision aid (PtDA) for emergency department (ED)-initiated buprenorphine treatment for opioid use disorder (OUD). The PtDA will be evaluated for acceptability, impact on patient knowledge, decisional conflict, and buprenorphine uptake compared to treatment as usual (TAU).

Interventions

BEHAVIORALPatient Decision Aid for Opioid Use Disorder

This will include information structured for patients about buprenorphine as a treatment options in the emergency department.

Sponsors

Medical University of South Carolina
Lead SponsorOTHER
National Institute on Drug Abuse (NIDA)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥18 * DSM-5 criteria for moderate-to-severe OUD * Speaks and reads English * Not currently prescribed MOUD * Post-ED discharge patients with access to video/email

Exclusion criteria

\- Prisoners

Design outcomes

Primary

MeasureTime frame
Acceptability of Intervention Measure (AIM)Day 1

Secondary

MeasureTime frameDescription
Knowledge about MOUDpre and post intervention on day 1, and at 7 daysThis is a multiple choice knowledge quiz
Treatment selectionDay 1
Decisional Conflict ScaleDay 1
Receipt of buprenorphineDay 1, 7

Countries

United States

Contacts

CONTACTLindsey Jennings, MD, MPH
jennil@musc.edu(843) 876-8023
PRINCIPAL_INVESTIGATORLindsey Jennings, MD, MPH

Medical University of South Carolina

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 25, 2026